To view the PDF file, sign up for a MySharenet subscription.

LITHA HEALTHCARE GROUP LIMITED - Disclosure of significant holding of Litha ordinary shares and change of board members

Release Date: 03/09/2013 11:27
Code(s): LHG     PDF:  
Wrap Text
Disclosure of significant holding of Litha ordinary shares and change of board members

LITHA HEALTHCARE GROUP LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2006/006371/06)
Share code: LHG
ISIN: ZAE000144671
(“Litha” or "the company")

DISCLOSURE OF SIGNIFICANT HOLDING OF LITHA ORDINARY SHARES AND
CHANGE OF BOARD MEMBERS

In accordance with the JSE Limited Listings Requirements and
Section 122 of the Companies Act 2008, shareholders are advised of
the following:

Paladin Labs Inc has increased its holding in the company from
242 174 123 (44.5%) to 313 782 748 (57.7%). The additional shares
were purchased from Blackstar Group SE (“Blackstar”).

As a result, Mr. Andrew Bonamour and Mr. William Marshall-Smith
from Blackstar have resigned from the board of Litha with effect
from the 29 August 2013. Blackstar played a pivotal role in the
listing of Myriad Medical Holdings Limited (“Myriad”) on AltX in
2006 and were the initiators of the purchase of Litha Healthcare
Holdings Proprietary Limited in which enabled Myriad to transfer
to the Main Board of the JSE, changing its name to Litha
Healthcare Group Limited in 2010. They were also key role players
in the acquisition of Pharmaplan Proprietary Limited in 2012. We
thank them for their commitment and expert contribution during
these vital years in Litha’s growth.


Midrand
3 September 2013

Merchant bank and sponsor
RAND MERCHANT BANK (a division of FirstRand Bank Limited)
 

Date: 03/09/2013 11:27:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story